UMass Boston

Tuberculosis (TB) Screening Questionnaire: All UMass Boston students are required to complete the web-based questionnaire by logging on to the MyHealthBeacon Portal. For instructions on accessing the form, read more here. 

• In addition to completing the TB questionnaire, some international students will be required to test after entering the US. Students coming from a high-risk country will be required to test for tuberculosis or submit documentation of a test administered after entry into the United States. UHS strongly recommends that students who are coming from a high-risk country have a test administered within 3 months from the anticipated date of entry into the United States. The U.S. Immigration Services may require testing for certain countries and students are encouraged to submit these documents. 

There are two forms of testing that we accept: 

• Tuberculosis skin test
• Blood test (IGRA)

A chest x-ray is not an acceptable test for TB. A chest x-ray is only required if someone tests positive. 

Students who test positive for TB must be evaluated by a Health care provider and cleared for travel. Please have your healthcare provider complete the TB Clearance Form.

Students with a history of a positive TB test should not be retested. Please have your healthcare provider complete the TB Clearance Form.

The requirements below are in addition to the all-student requirements listed above. 

Measles, Mumps, and Rubella (MMRII)

• Two (2) doses
  • The first dose must be administered after the first birthday
  • A minimum of 4 weeks (28 days) between the 1st and 2nd dose is required
    -or-
• Serologic (blood test) evidence of immunity
  • An official copy of the lab report must be submitted. 
  • Submissions that do not include a copy of the lab report will not be processed

Students born in the U.S. before 1957 are exempt and considered immune (exemption does not apply to CNHS students).  

Hepatitis B

• Three (3) doses of Hepatitis B or Hep A & B combined
  • Minimum of 4 weeks (28 days) between first and second doses
  • Minimum of 6 months between first and third doses
    -or-
• Two (2) doses of HEPISLAV-B 
  • Minimum of 4 weeks (28 days) between doses
  • Must be at least 18 years old
    -or-
• Serologic (blood test) evidence of immunity
  • An official copy of the lab report must be submitted.
  • Submissions that do not include a copy of the lab report will not be processed.

Pertussis (Tdap) 

• One (1) dose
  • Must be administered on or after age 7 and no earlier than June 2005.

Please note that in the U.S., the Tdap vaccine is the only vaccine that contains the required dose of Pertussis that satisfies this requirement. The Tdap vaccine also contains an adequate dose of Tetanus and Diphtheria (Td) that satisfies the 10 year booster dose requirement for Td.

Tetanus & Diphtheria (Td)

• One (1) booster dose of a vaccine containing Tetanus and Diphtheria is required every 10 years after an age-appropriate dose of a Tdap vaccine (administered on or after age 7).

Varicella (VZV)

• Two (2) doses
  • The first dose must be administered after the first birthday
  • A minimum of 4 weeks (28 days) between the 1st and 2nd is required
    -or-
• Serologic (blood test) evidence of immunity
  • An official copy of the lab report must be submitted. 
  • Submissions that do not include a copy of the lab report will not be processed.
    -or-
• Official letter from licensed health care provider indicating the age of chickenpox illness
• Students born in the U.S. before 1957 are exempt and considered immune (exemption does not apply to CNHS students). 

Meningococcal Conjugate: MenACWY (MCV4)
Required for all full-time students under 22 years of age and all students living on-campus in the dorms.

• One (1) dose
  • Must be administered on or after the 16^th birthday

Influenza (Flu)

• One dose is recommended annually for all college students. CNHS students are required to have the influenza vaccine annually.

Meningococcal Serotype B (Men B)

• Men B vaccine series may be administered to adolescents and young adults aged 16–23 years to provide short-term protection against most strains of serogroup B meningococcal disease.

Human Papillomavirus (HPV)

• HPV is the most common sexually transmitted infection (STI) and is so common that nearly all sexually active individuals get it at some point. There are many different types of HPV. Some types can cause health problems, such as genital warts and cancers.
• The HPV vaccine is safe and effective and can protect males and females against diseases (including cancers) caused by the Human Papillomavirus.

COVID-19 Updated Vaccine

• UMass Boston strongly recommends all students receive an updated COVID-19 dose when eligible.
  • Please visit the CDC's official COVID-19 Vaccine page for current updates and eligibility guidance.

All required immunizations can be obtained off-campus by a provider of choice or at University Health Services.

Students attending UMass Boston may request an exemption from any immunization requirement, subject to religious and disability accommodations pursuant to state and federal law. 

An exemption cannot be submitted for the Tuberculosis (TB) Screening Questionnaire, as all students must complete this web-based questionnaire on the My Health Beacon Portal.

Read more about Exemptions from Requirements »